SCHEMBL20829552

SCHEMBL20829552

IC1c2ccccc2-c2ccncc2-c2ccccc21

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.47
MAOB P27338 1/20 0.47
CYP19A1 P11511 5/20 0.37
LIMK1 P53667 4/20 0.36
CYP11B2 P19099 4/20 0.34
RPS6KA3 P51812 2/20 0.33
CDC25B P30305 1/20 0.33
TNF P01375 1/20 0.33
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
MAPK10 P53779 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
GPR3 P46089 1/20 0.32
HTR2A P28223 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14380259 0.81 MAOA (0.65) MAOAMAOBCYP19A1LIMK1CYP11B2
SCHEMBL20829599 0.81 GPR3 (0.44) MAOACYP19A1NPC1MAPTRAB9A
SCHEMBL28512593 0.81 MAOA (0.65) MAOAMAOBCYP19A1LIMK1CYP11B2
SCHEMBL19764657 0.81 MAOA (0.65) MAOAMAOBCYP19A1LIMK1CYP11B2
SCHEMBL7930812 0.78 GPR3 (0.46) CYP19A1GPR3HTR2A
SCHEMBL22413744 0.77 MAOA (0.43) MAOAMAOBCYP19A1LIMK1CYP11B2
SCHEMBL20829703 0.73 ATM (0.36) CYP19A1CDC25BMAPK10
SCHEMBL12854062 0.71 RPS6KA3 (0.56) MAOAMAOBRPS6KA3TNFMAPT
SCHEMBL12854064 0.71 RPS6KA3 (0.56) MAOAMAOBRPS6KA3TNFMAPT
SCHEMBL3066734 0.71 MAOA (0.87) MAOAMAOBLIMK1CDC25BNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3686201-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2020-07-29 EP disclosed
WO-2019052565-A1 INFLUENZA VIRUS REPLICATION INHIBITOR AND USE THEREOF 广东东阳光药业有限公司 2019-03-21 WO disclosed